Inke highlights the importance of European capital markets in EIB interview

Inke recently had the privilege of participating in an exclusive interview with the European Investment Bank (EIB), where our CEO, Miquel Bachs Taberner, shared insights on the vital role of European capital markets in driving pharmaceutical innovation and growth.

During the discussion, Miquel Bachs emphasized how access to local financing is crucial for scale-ups like Inke, allowing companies to expand, invest in research and development, and remain competitive on a global scale while staying rooted in Europe. The conversation also touched on the European Tech Champions Initiative, an EIB-backed program designed to strengthen Europe’s innovation landscape and support high-growth companies in their scaling efforts.

At Inke, we specialize in the development and manufacturing of micronized Active Pharmaceutical Ingredients (APIs), particularly in the respiratory field. As the pharmaceutical industry continues to evolve, strong and reliable financial support is key to sustaining innovation, ensuring regulatory compliance, and fostering European talent.

We appreciate the EIB’s commitment to creating a thriving ecosystem for European innovators and supporting companies like Inke in our mission to develop high-quality pharmaceutical solutions.

📺 Watch the full interview here or visit our Youtube Channel